Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Genitourinary 1

Conditions

Renal Insufficiency 1Lymphoma, Follicular 1Kidney Failure, Chronic 1

Interventions

Cyclophosphamide 8fludarabine phosphate 6Peripheral Blood Stem Cell Transplantation 6Mycophenolic Acid 6Flow Cytometry 6Therapeutics 5Whole-Body Irradiation 4Radiotherapy 4Polymerase Chain Reaction 4Cyclosporine 4Busulfan 4Antilymphocyte Serum 4Tacrolimus 3Methylprednisolone 3Methotrexate 3Immunoenzyme Techniques 3thymoglobulin 2liposomal amphotericin B 2aflibercept 2Vorinostat 2Thiotepa 2Rituximab 2Psychiatric Rehabilitation 2Prednisone 2Ondansetron 2Melphalan 2Itraconazole 2Immunologic Techniques 2Filgrastim 2Etoposide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Follicular × Duration of Therapy × Genitourinary × Clear all
NCT00418366 2015-08-19

A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008)

Merck Sharp & Dohme LLC

Phase 1 Completed
24 enrolled
GenitourinaryLymphoid

Kidney Failure, Chronic, Lymphoma, Follicular, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡